V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20177717 | 20066329 | 1.7 | 70 | Curative (C) | 2018-09-05 | 2018-09-05 | Fluouracil continuous infusion | 02 | N | FLUOROURACIL | 101378833 |
| 20177719 | 20066330 | 1.75 | 82 | Adjuvant (A) | 2018-09-22 | 2018-10-04 | Fluorouricil + Folonic Acid (MdG) | N | N | FLUOROURACIL | 101214739 |
| 20177720 | 20066331 | 1.67 | 77.4 | Adjuvant (A) | 2019-02-06 | 2019-03-15 | FLUOROURACIL | N | N | FLUOROURACIL | 101854141 |
| 20177721 | 20066332 | 1.68 | 0 | Neo-adjuvant (N) | 2018-10-28 | 2018-10-28 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101244893 |
| 20177724 | 20066333 | 1.49 | 49.8 | Adjuvant (A) | 2018-07-26 | 2018-07-31 | FLUOROURACIL | N | N | FLUOROURACIL | 101236012 |
| 20177726 | 20066334 | 1.75 | 63.2 | Adjuvant (A) | 2017-01-13 | 2017-01-22 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101252035 |
| 20177727 | 20066335 | null | null | Neo-adjuvant (N) | 2018-04-26 | 2018-05-08 | Fluorouracil + Folinic Acid Weekly | N | N | FLUOROURACIL | 101492864 |
| 20177732 | 20066336 | 1.74 | 87.3 | Palliative (P) | 2017-07-28 | 2017-08-07 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101461444 |
| 20177743 | 20066337 | 1.56 | 70 | Palliative (P) | 2019-09-08 | 2019-09-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100830721 |
| 20177744 | 20066338 | null | null | Adjuvant (A) | 2018-02-08 | 2018-02-08 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101134581 |
| 20177751 | 20066339 | 1.56 | 53.6 | null | 2018-08-14 | 2018-08-14 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101345094 |
| 20177752 | 20066340 | 1.52 | 83.4 | Adjuvant (A) | 2019-08-11 | 2019-08-14 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 101212430 |
| 20177753 | 20066341 | 1.52 | 68 | Neo-adjuvant (N) | 2019-03-04 | 2019-03-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100869807 |
| 20177756 | 20066342 | 1.67 | 73.2 | Adjuvant (A) | 2017-01-27 | 2017-01-27 | FLUOROURACIL | 02 | N | FLUOROURACIL | 100809540 |
| 20177758 | 20066343 | 1.75 | 120 | Neo-adjuvant (N) | 2018-02-13 | 2018-02-19 | ECX | 02 | Y | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100839576 |
| 20177762 | 20066344 | 1.77 | 94.3 | Adjuvant (A) | 2019-09-29 | 2019-10-18 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 100007189 |
| 20177763 | 20066345 | 1.74 | 45 | Adjuvant (A) | 2017-04-14 | 2017-05-02 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100859798 |
| 20177768 | 20066346 | null | null | Adjuvant (A) | 2019-09-24 | 2019-09-24 | Fluouracil continuous infusion | 02 | N | FLUOROURACIL | 101835211 |
| 20177772 | 20066347 | 1.81 | 66.4 | Adjuvant (A) | 2018-05-26 | 2018-06-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100845729 |
| 20177780 | 20066348 | null | 69 | Neo-adjuvant (N) | 2016-07-10 | 2016-07-25 | ECX | null | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101808289 |
| 20177782 | 20066349 | 1.65 | 75.8 | Adjuvant (A) | 2016-02-15 | 2016-03-06 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100412035 |
| 20177788 | 20066350 | 1.71 | 88.3 | Neo-adjuvant (N) | null | 2016-09-07 | ECX | 02 | N | FLUOROURACIL | 101613776 |
| 20177793 | 20066351 | 1.64 | 73.8 | Neo-adjuvant (N) | 2019-09-23 | 2019-10-08 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100146173 |
| 20177810 | 20066352 | 1.83 | 70 | Adjuvant (A) | 2017-05-18 | 2017-05-18 | FLUOROURACIL | 02 | N | FLUOROURACIL | 101489261 |
| 20177811 | 20066353 | null | null | Adjuvant (A) | 2017-08-10 | 2017-08-10 | Fluorouricil + Folonic Acid (MdG) | 2 | N | FLUOROURACIL | 100641570 |
| 20177813 | 20066354 | 1.34 | 71.8 | Palliative (P) | 2018-04-01 | 2018-04-02 | ECX | 02 | N | FLUOROURACIL | 101655478 |
| 20177816 | 20066355 | 1.56 | 82 | Curative (C) | 2018-08-14 | 2018-08-27 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100503804 |
| 20177820 | 20066356 | 1.67 | 70 | Curative (C) | 2016-09-01 | 2016-09-22 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100451201 |
| 20177825 | 20066357 | 1.69 | 90.4 | Palliative (P) | 2016-06-26 | 2016-07-04 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100760700 |
| 20177826 | 20066358 | 1.59 | 86.4 | Palliative (P) | 2018-05-12 | 2018-05-19 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100305096 |
| 20177838 | 20066359 | 1.64 | 71.4 | Disease modification (D) | 2020-01-20 | 2020-02-06 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100367023 |
| 20177845 | 20066360 | null | null | Adjuvant (A) | 2017-01-14 | 2017-02-11 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 101779759 |
| 20177856 | 20066361 | null | null | Neo-adjuvant (N) | 2018-02-23 | 2018-03-11 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100762300 |
| 20177867 | 20066362 | 1.6 | 62 | Curative (C) | 2019-12-21 | 2020-01-01 | Fluorouricil + Folonic Acid (MdG) | 02 | N | FLUOROURACIL | 100688554 |
| 20177872 | 20066363 | 1.72 | 79 | Neo-adjuvant (N) | 2019-09-24 | 2019-09-25 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100128990 |
| 20177882 | 20066364 | 1.58 | 68.1 | Palliative (P) | 2018-06-15 | 2018-07-03 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100393861 |
| 20177887 | 20066365 | 1.56 | 64.3 | Neo-adjuvant (N) | 2017-09-10 | 2017-09-10 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100163044 |
| 20177889 | 20066366 | 1.7 | 80 | Adjuvant (A) | 2018-06-03 | 2018-06-21 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100978731 |
| 20177890 | 20066367 | 1.72 | 108.5 | Neo-adjuvant (N) | 2017-07-08 | 2017-07-17 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100026711 |
| 20177894 | 20066368 | 1.66 | 83.3 | Palliative (P) | 2017-05-19 | 2017-06-06 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100767125 |
| 20177902 | 20066369 | null | null | Curative (C) | 2019-03-05 | 2019-03-25 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100935562 |
| 20177915 | 20066370 | 1.6 | 64.1 | Curative (C) | 2017-06-20 | 2017-07-01 | Fluorouracil + Folinic Acid Weekly | 02 | N | FLUOROURACIL | 100860576 |
| 20177918 | 20066371 | 1.67 | 62.8 | Palliative (P) | 2017-08-05 | 2017-08-05 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100329804 |
| 20177923 | 20066372 | 1.66 | 81.6 | Palliative (P) | 2017-12-20 | 2018-01-01 | Fluorouracil + Folinic Acid Weekly | 02 | null | FLUOROURACIL | 101553344 |
| 20177926 | 20066373 | 1.73 | 117.4 | Neo-adjuvant (N) | 2019-08-28 | 2019-09-12 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100634391 |
| 20177929 | 20066374 | 1.63 | 95 | Palliative (P) | 2017-09-04 | 2017-09-08 | ECX | 02 | null | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100758572 |
| 20177931 | 20066375 | 1.71 | 82.7 | Palliative (P) | 2019-07-04 | 2019-07-15 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100044823 |
| 20177932 | 20066376 | 1.71 | 55.6 | Neo-adjuvant (N) | 2018-05-26 | 2018-06-02 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 100569260 |
| 20177933 | 20066377 | 1.68 | 85 | Neo-adjuvant (N) | 2019-08-03 | 2019-08-08 | ECX | 02 | N | FLUOROURACIL | 100944425 |
| 20177936 | 20066378 | 1.65 | 73.7 | Palliative (P) | 2017-12-25 | 2017-12-31 | ECX | 02 | N | CISPLATIN + CAPECITABINE + EPIRUBICIN | 101197934 |